API PHARMA

Liège ·KBO/BCE: BE 0805.949.739

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	08-07-2025	23 d early	2025-00246669
31-12-2023	31-07-2024	09-07-2024	22 d early	2024-00232616

Metric	This company	Sector median	Position in the sector
Solvency	45.8%	20.4%	better than 72% of 6698 sector peers
Net result	€35k	€4k	better than 84% of 6678 sector peers
Equity	€37k	€16k	better than 66% of 6712 sector peers
Gross operating margin	€50k	€24k	better than 66% of 6657 sector peers
Total assets	€81k	€94k	better than 45% of 6702 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€81k
Fixed assets	21/28	€24k
Tangible fixed assets	22/27	€24k
Current assets	29/58	€58k
Amounts receivable within one year	40/41	€11k
Cash & bank	54/58	€47k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€81k
Equity	10/15	€37k
Contributions / capital	10/11	€2k
Accumulated profits (losses)	14	€35k
Amounts payable	17/49	€44k
Amounts payable after one year	17	€11k
Amounts payable within one year	42/48	€33k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€50k
Operating result	9901	€45k
Financial charges	65	€278
Result before taxes	9903	€45k
Income taxes	67/77	€10k
Net result for the period	9904	€35k
Result to be appropriated	9905	€35k

Summary